Novavax announced positive phase 1 data for its COVID-19 vaccine candidate
On Aug. 4, 2020, Novavax announced Phase 1 data from its Phase 1/2 randomized, observer-blinded, placebo-controlled trial of…
On Aug. 4, 2020, Novavax announced Phase 1 data from its Phase 1/2 randomized, observer-blinded, placebo-controlled trial of…
On Aug. 3, 2020, Todos Medical announced a partnership with PATHNOVA, a Singapore-based clinical laboratory, for the Company’s…
On Aug. 1, 2020, Novavax announced it had received approval to start human trials in India for the…
On Jul. 31, 2020, researchers from the Pacific Northwest National Laboratory (PNNL) and Oregon Health & Science University…
On Jul. 30, 2020, Seqirus announced it had begun shipping its portfolio of seasonal influenza vaccines to customers…
On Jul. 30, 2020, INOVIO announced that its COVID-19 DNA vaccine INO-4800 targeting SARS-CoV-2 was effective in protecting…
On Jul. 29, 2020, Regeneron announced that the Biomedical Advanced Research and Development Authority (BARDA) had entered into…
On Jul. 29, 2020, Sanofi and GSK announced an agreement with the UK government for the supply of…
On Jul. 28, 2020, Moderna announced a preclinical study evaluating mRNA-1273, its vaccine candidate against COVID-19, was published…
On Jul. 27, 2020, the National Institutes of Health (NIH) announced that a phase 3 clinical trial designed…
On Jul. 27, 2020, MediciNova announced an agreement with BioComo and Mie University (Mie prefecture, Japan) for joint…
On Jul. 27, 2020, Moderna announced that the Phase 3 study of its mRNA vaccine candidate (mRNA-1273) against…
On Jul. 27, 2020, FUJIFILM Diosynth Biotechnologies (FDB) and Texas A&M announced they mass will produce vaccines as…
On Jul. 26, 2020, Moderna announced a modification to its contract with the Biomedical Advanced Research and Development…
On Jul. 23, 2020, Novavax and FUJIFILM Diosynth Biotechnologies announced an agreement to manufacture bulk drug substance for…
On Jul. 21, 2020, National Institutes of Health (NIH) researchers reported early results from the first COVID-19 vaccine…
On Jul. 21, 2020, researchers from the National Institutes of Health (NIH) announced that early results from the…
On Jul. 16, 2020, Dynavax Technologies and the Icahn School of Medicine at Mount Sinai announced they had…
On Jul. 15, 2020, Tevogen Bio announced its intention to evaluate its proprietary antigen-specific T cell technology as…
On Jul. 14, 2020, Moderna announced the publication of an interim analysis of the open-label Phase 1 study…
On Jul. 14, 2020, Pascal Biosciences announced it had discovered certain cannabinoids that block replication of SARS-CoV-2, the…
On Jul. 13, 2020, Tonix Pharmaceuticals announced a new preclinical research and option agreement with Kansas State University…
On Jul. 9, 2020 Moderna and Laboratorios Farmaceuticos Rovi announced a collaboration for large-scale, commercial fill-finish manufacturing of…
On Jul. 8, 2020, Moderna announced that it had completed enrollment for both cohorts of the Phase 2…
On Jul. 8, 2020, BD (Becton, Dickinson) announced the formation of a strategic, public-private partnership with the Biomedical…
On Jul. 8, 2020, the European Commission announced regulatory approval for the first adjuvanted quadrivalent influenza vaccine to…
On Jul. 8, 2020, the Fred Hutchinson Cancer Research Center was named the coordinating center for vaccine clinical…
On Jul. 7, 2020, Novavax announced that it had been selected to participate in Operation Warp Speed, a…
On Jul. 7, 2020, Regeneron announced that, as part of Operation Warp Speed, the Biomedical Advanced Research and…
On Jul. 6, 2020, Anixa Biosciences announced that it and partner OntoChem had completed the initial in silico…